June 9, 2020 / 10:57 PM / a month ago

BRIEF-Adalta Gets Nod To Begin Phase I Trial Of AD-214

June 10 (Reuters) - Adalta Ltd:

* RECEIVES APPROVAL TO COMMENCE PHASE I CLINICAL TRIAL OF AD-214

* FIRST HEALTHY VOLUNTEER SUBJECT EXPECTED TO RECEIVE AD-214 IN LATE JULY

* TOP-LINE SAFETY RESULTS FROM HEALTHY VOLUNTEER COMPONENT EXPECTED AT BEGINNING OF CY2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below